The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs)

Xenobiotica

Volumn 43, Issue 5, 2013, Pages 409-420

  Rydevik, Axel ^a   Thevis, Mario ^b   Krug, Oliver ^b   Bondesson, Ulf ^a,c   Hedeland, Mikael ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^c NATIONAL VETERINARY INSTITUTE   (Sweden)

Author keywords

Doping control; Mass spectrometry; MSE; Q ToF; UPLC

Indexed keywords

NITROREDUCTASE; SELECTIVE ANDROGEN RECEPTOR MODULATOR;

ACETYLATION; ARTICLE; CONTROLLED STUDY; CUNNINGHAMELLA ELEGANS; DEACETYLATION; FUNGAL METABOLISM; HUMAN; HUMAN CELL; HYDROXYLATION; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; SULFONATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANDROGENS; ANIMALS; CUNNINGHAMELLA; DOPING IN SPORTS; HORSES; HUMANS; PERFORMANCE-ENHANCING SUBSTANCES; RECEPTORS, ANDROGEN; SUBSTANCE ABUSE DETECTION;

CAENORHABDITIS ELEGANS; CUNNINGHAMELLA ELEGANS; EQUIDAE; FUNGI; MAMMALIA;

EID: 84875861103     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2012.729102     Document Type: Article

References (20)

1. Chen J, Kim J, Dalton JT. (2005). Discovery and therapeutic promise of selective androgen receptor modulators. Mol Interv 5: 173-188. (Pubitemid 41018274)
2. Dalton JT, Mukherjee A, Zhu Z, Kirkovsky L, Miller DD. (1998). Discovery of nonsteroidal androgens. Biochem Biophys Res Commun 244: 1-4. (Pubitemid 28419889)
3. Gao W, Wu Z, Bohl CE, Yang J, Miller DD, Dalton JT. (2006). Characterization of the in vitro metabolism of selective androgen receptor modulator using human, rat, and dog liver enzyme preparations. Drug Metab Dispos 34: 243-253. (Pubitemid 43145026)
4. Grata E, Perrenoud L, Saugy M, Baume N. (2011). SARM-S4 and metabolites detection in sports drug testing: A case report. Forensic Sci Int 213: 104-108.
5. Krug O, Thomas A, Beuck S, Schenk I, Machnik M, Schanzer W, Bondesson U, Hedeland M, Thevis M. (2012). Characterization of in vitro synthesized equine metabolites of the selective androgen receptor modulators S24 and S4. J Equine Vet Sci 32: 562-568.
6. Kuuranne T, Leinonen A, Schanzer W, Kamber M, Kostiainen R, Thevis M. (2008). Aryl-propionamide-derived selective androgen receptor modulators: Liquid chromatography-tandem mass spectrometry characterization of the in vitro synthesized metabolites for doping control purposes. Drug Metab Dispos 36: 571-581. (Pubitemid 351397983)
7. Ma B, Huang HH, Chen XY, Sun YM, Lin LH, Zhong DF. (2007). Biotransformation of metoprolol by the fungus Cunninghamella blakesleeana. Acta Pharmacol Sin 28: 1067-1074. (Pubitemid 47020478)
8. Mohler ML, Nair VA, Hwang DJ, Rakov IM, Patil R, Miller DD. (2005). Nonsteroidal tissue selective androgen receptor modulators: A promising class of clinical candidates. Expert Opin Ther Pat 15: 1565-1585. (Pubitemid 41671618)
9. Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD. (2009). Nonsteroidal selective androgen receptor modulators (SARMs): Dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem 52: 3597-3617.
10. Pearce CM, Lushnikova MV. (2006). Microbiological production of omeprazole metabolites by Cunninghamella elegans. Journal of Molecular Catalysis B: Enzymatic 87-91. (Pubitemid 44118809)
11. Rydevik A, Bondesson U, Hedeland M. (2012). Structural elucidation of phase I and II metabolites of bupivacaine in horse urine and fungi of the Cunninghamella species using liquid chromatography/multi-stage mass spectrometry. Rapid Commun Mass Spectrom 26: 1338-1346.
12. Tevell Aberg A, Olsson C, Bondesson U, Hedeland M. (2009). A mass spectrometric study on meloxicam metabolism in horses and the fungus Cunninghamella elegans, and the relevance of this microbial system as a model of drug metabolism in the horse. J Mass Spectrom 44: 1026-1037.
13. Tevell Aberg A, Loefgren H, Bondesson U, Hedeland M. (2010). Structural elucidation of Noxidized clemastine metabolites by liquid chromatography/tandem mass spectrometry and the use of Cunninghamella elegans to facilitate drug metabolite identification. Rapid Commun Mass Spectrom 24: 1447-1456.
14. Thevis M, Kamber M, Schanzer W. (2006). Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Commun Mass Spectrom 20: 870-876. (Pubitemid 43326696)
15. Thevis M, Geyer H, Kamber M, Schanzer W. (2009). Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. Drug Test Anal 1: 387-392.
16. Thevis M, Gerace E, Thomas A, Beuck S, Geyer H, Schlorer N, Kearbey JD, Dalton JT, Schanzer W. (2010a). Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens. Drug Test Anal 2: 589-598.
17. Thevis M, Thomas A, Fussholler G, Beuck S, Geyer H, Schanzer W. (2010b). Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. Rapid Commun Mass Spectrom 24: 2245-2254.
18. Thevis M, Thomas A, Moller I, Geyer H, Dalton JT, Schanzer W. (2011). Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. Rapid Commun Mass Spectrom 25: 2187-2195.
19. Wu D, Wu Z, Yang J, Nair VA, Miller DD, Dalton JT. (2006). Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: Implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic characteristics of a propanamide in preclinical study. Drug Metab Dispos 34: 483-494. (Pubitemid 43290908)
20. Zhang D, Evans FE, Freeman JP, Duhart B Jr, Cerniglia CE. (1995). Biotransformation of amitriptyline by Cunninghamella elegans. Drug Metab Dispos 23: 1417-1425. (Pubitemid 26007848)